Brief: Allurion Intends To Appeal NYSE Notice Of Delisting, Execute Plan To Regain Compliance, And Expects To Continue Trading On NYSE
02/03/2026 14:02
March 2 (Reuters) - Allurion Technologies Inc ALUR.N: ALLURION INTENDS TO APPEAL NYSE NOTICE OF DELISTING, EXECUTE PLAN TO REGAIN COMPLIANCE, AND EXPECTS TO CONTINUE TRADING ON NYSE Source text: ID:nBw9HdDl0a Further company coverage: ALUR.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allurion Technologies
See all newsBrief: Allurion Technologies Inc - Sees Growing Demand From Patients Discontinuing Glp-1 Therapy
Brief: Allurion Intends To Appeal NYSE Notice Of Delisting, Execute Plan To Regain Compliance, And Expects To Continue Trading On NYSE
Brief: NYSE To Commence Delisting Proceedings Against Allurion Technologies, Inc.
Allurion rises on plan to offer discounted weight-loss drug Mounjaro in Argentina
Allurion rises after strong weight-loss data from combination therapy